ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1381

Skeletal Muscle Cytokine and Myostatin Responses to High-Intensity Interval Training in Rheumatoid Arthritis Contrasted with Prediabetes Mellitus

Brian J. Andonian1, David Bartlett2, Virginia B. Kraus3, Janet Huebner2, William E. Kraus4 and Kim M. Huffman5, 1Rheumatology, Duke University Medical Center, Durham, NC, 2Duke University, Durham, NC, 3Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, 4Duke University School of Medicine, Durham, NC, 5School of Medicine, Division of Rheumatology, Immunology and Molecular Physiology and Durham VA Medical Center, Duke University, Durham, NC

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: cytokines, exercise, muscle biopsy and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster II: Pathophysiology, Autoantibodies, and Disease Activity Measures

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Sarcopenic obesity and the associated risk of cardiovascular disease (CVD) and mortality in rheumatoid arthritis (RA) may be related to dysregulated skeletal muscle remodeling (Huffman et al. Arthritis Research & Therapy (2017); 19:12). Skeletal muscle remodeling relies on coordinated signaling through cytokines and myokines. We hypothesized that exercise training-induced alterations in muscle cytokines and myokines would reprogram muscle remodeling differently in (RA) versus those with prediabetes (PD). In this study, we investigated relationships between skeletal muscle cytokines and myostatin in patients with RA and PD before and after a high-intensity interval-based training (HIIT) program.

Methods:

All RA patients in this study satisfied 1987 ACR criteria. Body composition was assessed with Bod Pod¨.  Using vastus lateralis biopsies, muscle (m) cytokines, mIL-1β, mIL-6, mIL-8, mTNF-α, mIL-10, and myostatin were quantified in RA (n=12) and pre-DM (n=9) before and after a 10-week supervised HIIT program. Continuous variables were compared using Students t-tests and Wilcoxon signed rank tests, dependent on normality. Correlations between muscle cytokines and clinical variables were compared using Spearmans rho.

Results:

The RA group was younger (age 63.9 vs 71.4 y; p<0.05) and thinner (BMI 27.4 vs 29.4 kg/m2; p<0.05) with similar cytokine yet lower muscle myostatin concentrations (Table 1). For both groups after HIIT training, there were no significant responses in cytokines or myostatin concentrations. While overall body composition changes were small in RA, an increase in lean mass correlated with decreases in mIL-6, mIL-1 β, and mTNF-α. A decrease in body fat percentage was correlated with a decrease in mTNF-α.

Conclusion:

While muscle cytokines in RA were comparable to an older, heavier, prediabetic group, RA myostatin was lower. As a potent negative regulator of skeletal muscle growth and hypertrophy, lower muscle myostatin suggests that in RA, sarcopenic obesity may be related to impaired myostatin signaling. Although 10 weeks of HIIT did not significantly alter mean group cytokine or myostatin concentrations, reductions in RA muscle cytokines were associated with improved body composition (greater lean mass and less body fat percentage). Thus, HIIT may improve coordination of cytokines and myokines critical for skeletal muscle remodeling.

Table 1

Skeletal Muscle Concentrations (pg/mL/µg)

All participants     (n=21)

Rheumatoid arthritis (n=12)

Pre-diabetes mellitus (n=9)

Pre-HIIT

Post-HIIT

Pre-HIIT

Post-HIIT

Pre-HIIT

Post-HIIT

   IL-1β

0.023 (0.075)

0.008 (0.006)

0.007 (0.005)

0.009 (0.006)

0.046 (0.115)

0.009 (0.006)

   IL-6

0.022 (0.053)

0.015 (0.008)

0.010 (0.006)

0.013 (0.007)

0.037 (0.081)

0.017 (0.009)

   IL-8

0.123 (0.234)

0.117 (0.132)

0.112 (0.212)

0.121 (0.168)

0.138 (0.273)

0.112 (0.081)

   TNF-α

0.013 (0.026)

0.010 (0.006)

0.008 (0.007)

0.012 (0.006)

0.022 (0.043)

0.009 (0.007)

   IL-10

0.012 (0.023)

0.006 (0.004)

0.009 (0.012)

0.006 (0.004)

0.015 (0.032)

0.005 (0.004)

   Myostatin

41.201 (87.883)

26.764 (16.079)

16.621 (7.463)

20.589 (8.685)

73.976 (130.80)*

34.314 (20.08)*

Continuous variable data are presented as means (SD). IL interleukin, TNF tumor necrosis factor, HIIT high intensity interval training

*p < 0.05 for comparisons between RA and pre-diabetes mellitus groups


Disclosure: B. J. Andonian, None; D. Bartlett, None; V. B. Kraus, None; J. Huebner, None; W. E. Kraus, None; K. M. Huffman, None.

To cite this abstract in AMA style:

Andonian BJ, Bartlett D, Kraus VB, Huebner J, Kraus WE, Huffman KM. Skeletal Muscle Cytokine and Myostatin Responses to High-Intensity Interval Training in Rheumatoid Arthritis Contrasted with Prediabetes Mellitus [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/skeletal-muscle-cytokine-and-myostatin-responses-to-high-intensity-interval-training-in-rheumatoid-arthritis-contrasted-with-prediabetes-mellitus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/skeletal-muscle-cytokine-and-myostatin-responses-to-high-intensity-interval-training-in-rheumatoid-arthritis-contrasted-with-prediabetes-mellitus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology